BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12011435)

  • 21. The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.
    Peshavaria M; Cissell MA; Henderson E; Petersen HV; Stein R
    Mol Endocrinol; 2000 Dec; 14(12):1907-17. PubMed ID: 11117522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells.
    Harmon JS; Stein R; Robertson RP
    J Biol Chem; 2005 Mar; 280(12):11107-13. PubMed ID: 15664999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MafA stability in pancreatic beta cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3.
    Han SI; Aramata S; Yasuda K; Kataoka K
    Mol Cell Biol; 2007 Oct; 27(19):6593-605. PubMed ID: 17682063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cDNA cloning and mRNA expression of canine pancreatic and duodenum homeobox 1 (Pdx-1).
    Takemitsu H; Yamamoto I; Lee P; Ohta T; Mori N; Arai T
    Res Vet Sci; 2012 Oct; 93(2):770-5. PubMed ID: 22172402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RIPE3b1 activator of the insulin gene is composed of a protein(s) of approximately 43 kDa, whose DNA binding activity is inhibited by protein phosphatase treatment.
    Zhao L; Cissell MA; Henderson E; Colbran R; Stein R
    J Biol Chem; 2000 Apr; 275(14):10532-7. PubMed ID: 10744746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucose-induced transcription of the insulin gene is mediated by factors required for beta-cell-type-specific expression.
    Sharma A; Stein R
    Mol Cell Biol; 1994 Feb; 14(2):871-9. PubMed ID: 8289826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative contribution of PDX-1, MafA and E47/beta2 to the regulation of the human insulin promoter.
    Docherty HM; Hay CW; Ferguson LA; Barrow J; Durward E; Docherty K
    Biochem J; 2005 Aug; 389(Pt 3):813-20. PubMed ID: 15862113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MafA has strong cell transforming ability but is a weak transactivator.
    Nishizawa M; Kataoka K; Vogt PK
    Oncogene; 2003 Sep; 22(39):7882-90. PubMed ID: 12970735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MafA is a key regulator of glucose-stimulated insulin secretion.
    Zhang C; Moriguchi T; Kajihara M; Esaki R; Harada A; Shimohata H; Oishi H; Hamada M; Morito N; Hasegawa K; Kudo T; Engel JD; Yamamoto M; Takahashi S
    Mol Cell Biol; 2005 Jun; 25(12):4969-76. PubMed ID: 15923615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of PDX-1 in activation of human insulin gene transcription.
    Le Lay J; Stein R
    J Endocrinol; 2006 Feb; 188(2):287-94. PubMed ID: 16461554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of MafA in pancreatic beta-cells.
    Kaneto H; Matsuoka TA; Kawashima S; Yamamoto K; Kato K; Miyatsuka T; Katakami N; Matsuhisa M
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):489-96. PubMed ID: 19393272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of PDX-1 and MafA as a potential therapeutic target for diabetes.
    Kaneto H; Miyatsuka T; Fujitani Y; Noguchi H; Song KH; Yoon KH; Matsuoka TA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S127-37. PubMed ID: 17449132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MafA regulates expression of genes important to islet beta-cell function.
    Matsuoka TA; Kaneto H; Stein R; Miyatsuka T; Kawamori D; Henderson E; Kojima I; Matsuhisa M; Hori M; Yamasaki Y
    Mol Endocrinol; 2007 Nov; 21(11):2764-74. PubMed ID: 17636040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.
    Seufert J; Weir GC; Habener JF
    J Clin Invest; 1998 Jun; 101(11):2528-39. PubMed ID: 9616224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor cycling on the insulin promoter.
    Barrow J; Hay CW; Ferguson LA; Docherty HM; Docherty K
    FEBS Lett; 2006 Jan; 580(2):711-5. PubMed ID: 16412423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the insulin control element and RIPE3b1 activators in glucose-stimulated transcription of the insulin gene.
    Sharma A; Fusco-DeMane D; Henderson E; Efrat S; Stein R
    Mol Endocrinol; 1995 Nov; 9(11):1468-76. PubMed ID: 8584024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The DNA binding activity of the RIPE3b1 transcription factor of insulin appears to be influenced by tyrosine phosphorylation.
    Matsuoka T; Zhao L; Stein R
    J Biol Chem; 2001 Jun; 276(25):22071-6. PubMed ID: 11309378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential introduction and dosage balance of defined transcription factors affect reprogramming efficiency from pancreatic duct cells into insulin-producing cells.
    Miyashita K; Miyatsuka T; Matsuoka TA; Sasaki S; Takebe S; Yasuda T; Watada H; Kaneto H; Shimomura I
    Biochem Biophys Res Commun; 2014 Feb; 444(4):514-9. PubMed ID: 24472553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the insulin gene by glucose: stimulation of trans-activation potency of human PDX-1 N-terminal domain.
    Shushan EB; Cerasi E; Melloul D
    DNA Cell Biol; 1999 Jun; 18(6):471-9. PubMed ID: 10390156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the role of E2A-encoded proteins in insulin gene transcription.
    Sharma A; Henderson E; Gamer L; Zhuang Y; Stein R
    Mol Endocrinol; 1997 Oct; 11(11):1608-17. PubMed ID: 9328343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.